Table of Contents Author Guidelines
International Journal of Medicinal Chemistry
Volume 2017, Article ID 1069718, 20 pages
https://doi.org/10.1155/2017/1069718
Review Article

Targeting Peroxisome Proliferator-Activated Receptors Using Thiazolidinediones: Strategy for Design of Novel Antidiabetic Drugs

Department of Pharmaceutical Chemistry, College of Pharmacy, Jazan University, P.O. Box 114, Jazan 45 142, Saudi Arabia

Correspondence should be addressed to Neelaveni Thangavel; ni.oc.oohay@4002pocgspinev

Received 24 February 2017; Revised 23 April 2017; Accepted 7 May 2017; Published 5 June 2017

Academic Editor: Benedetto Natalini

Copyright © 2017 Neelaveni Thangavel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [6 citations]

The following is the list of published articles that have cited the current article.

  • Pablo Villa-Pérez, Mercedes Cueto, Ana Díaz-Marrero, Carmen Lobatón, Alfredo Moreno, Germán Perdomo, and Irene Cózar-Castellano, “Leptolide Improves Insulin Resistance in Diet-Induced Obese Mice,” Marine Drugs, vol. 15, no. 9, pp. 289, 2017. View at Publisher · View at Google Scholar
  • George A. Robinson, Kirsty E. Waddington, Ines Pineda-Torra, and Elizabeth C. Jury, “Transcriptional Regulation of T-Cell Lipid Metabolism: Implications for Plasma Membrane Lipid Rafts and T-Cell Function,” Frontiers in Immunology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Lars Porskjær Christensen, and Rime Bahij El-Houri, “Development of an In Vitro Screening Platform for the Identification of Partial PPARγ Agonists as a Source for Antidiabetic Lead Compounds,” Molecules, vol. 23, no. 10, pp. 2431, 2018. View at Publisher · View at Google Scholar
  • Chien-Hung Lin, Christopher J Nicol, Yi-Chuan Cheng, Shiang-Jiuun Chen, Chia-Hui Yen, Rong-Nan Huang, and Ming-Chang Chiang, “Rosiglitazone rescues human neural stem cells from Amyloid-beta induced ER stress via PPARγ dependent signaling,” Experimental Cell Research, 2018. View at Publisher · View at Google Scholar
  • Waquar Ahsan, “The Journey of Thiazolidinediones as Modulators of PPARs for the Management of Diabetes: A Current Perspective,” Current Pharmaceutical Design, vol. 25, no. 23, pp. 2540–2554, 2019. View at Publisher · View at Google Scholar
  • Ping Zhou, Weijie Xie, Shuaibing He, Yifan Sun, Xiangbao Meng, Guibo Sun, and Xiaobo Sun, “Ginsenoside Rb1 as an Anti-Diabetic Agent and Its Underlying Mechanism Analysis,” Cells, vol. 8, no. 3, pp. 204, 2019. View at Publisher · View at Google Scholar